Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | P-glycoprotein-2, putative | 0.0113 | 0.0721 | 0.0721 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0113 | 0.0721 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0.0127 | 0.0127 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0113 | 0.0721 | 1 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0079 | 0.0371 | 0.5144 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0055 | 0.0127 | 0.1756 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0113 | 0.0721 | 1 |
Leishmania major | p-glycoprotein | 0.0113 | 0.0721 | 0.1467 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0113 | 0.0721 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0113 | 0.0721 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0113 | 0.0721 | 1 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0055 | 0.0127 | 0.1756 |
Toxoplasma gondii | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | ABC transporter, putative | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0079 | 0.0371 | 0.5144 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0055 | 0.0127 | 0.1756 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | P-glycoprotein-5 | 0.0113 | 0.0721 | 0.0721 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.052 | 0.4918 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0113 | 0.0721 | 1 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0113 | 0.0721 | 0.5 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.0113 | 0.0721 | 0.0721 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0055 | 0.0127 | 0.1756 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0113 | 0.0721 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0055 | 0.0127 | 0.1756 |
Trypanosoma brucei | inositol phosphorylceramide synthase | 0.0055 | 0.0127 | 0.0258 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0055 | 0.0127 | 0.1756 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0.0127 | 0.0127 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0055 | 0.0127 | 0.1756 |
Entamoeba histolytica | P-glycoprotein-1 | 0.0113 | 0.0721 | 0.0721 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.052 | 0.4918 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0055 | 0.0127 | 0.1756 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0.0127 | 0.0127 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | taga, putative | 0.0113 | 0.0721 | 1 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0113 | 0.0721 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.0721 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0.0127 | 0.0127 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.0721 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0709 | 0.9825 |
Trichomonas vaginalis | abcb9, putative | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0111 | 0.0709 | 0.9825 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0111 | 0.0709 | 0.9825 |
Onchocerca volvulus | 0.0113 | 0.0721 | 1 | |
Trichomonas vaginalis | ABC transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Brugia malayi | multidrug resistance protein 3 | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.0113 | 0.0721 | 0.0721 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0113 | 0.0721 | 1 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0079 | 0.0371 | 0.5144 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Schistosoma mansoni | smdr2 | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0113 | 0.0721 | 0.0721 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.052 | 0.4918 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0113 | 0.0721 | 1 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.0113 | 0.0721 | 0.1467 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0079 | 0.0371 | 0.5144 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0055 | 0.0127 | 0.1756 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0113 | 0.0721 | 1 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0113 | 0.0721 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.052 | 0.4918 | 1 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0055 | 0.0127 | 0.1756 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0055 | 0.0127 | 0.1756 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0113 | 0.0721 | 1 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0055 | 0.0127 | 0.1756 |
Schistosoma mansoni | multidrug resistance protein | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Trypanosoma brucei | ceramide phosphorylethanolamine synthase | 0.0055 | 0.0127 | 0.0258 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0.0127 | 0.0127 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0055 | 0.0127 | 0.1756 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0113 | 0.0721 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0127 | 0.1756 |
Brugia malayi | ABC transporter family protein | 0.0113 | 0.0721 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0113 | 0.0721 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.052 | 0.4918 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0113 | 0.0721 | 1 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0113 | 0.0721 | 0.0721 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0055 | 0.0127 | 0.1756 |
Entamoeba histolytica | hypothetical membrane-spanning protein | 0.0055 | 0.0127 | 0.0127 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.